80 results
8-K
EX-2.1
AXLA
Axcella Health Inc.
1 Nov 23
Departure of Directors or Certain Officers
4:05pm
of cash and/or property to satisfy claims against the Company, including, without limitation, tax obligations, all expenses related to the sale
8-K
EX-4.1
AXLA
Axcella Health Inc.
18 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:31pm
not specify a cost basis calculation method, then we have defaulted to the first in, first out (FIFO) method. Please consult your tax advisor if you
PRE 14A
zgxaeyk9dddkg0o6
7 Aug 23
Preliminary proxy
4:15pm
8-K
EX-10.1
04tkr3ecnirg7fk cvj
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
424B5
hhdz7x
13 Oct 22
Prospectus supplement for primary offering
7:55am
8-K
EX-10.1
i3u rzize1w4
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
b8qo8y 9xtcq8
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
r0sbgt ngv5k79
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am